{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T02:51:47Z","timestamp":1773370307185,"version":"3.50.1"},"reference-count":39,"publisher":"Instituto Nacional de Salud (Colombia)","issue":"Sp. 1","license":[{"start":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T00:00:00Z","timestamp":1717113600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T00:00:00Z","timestamp":1717113600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["revistabiomedica.org"],"crossmark-restriction":false},"short-container-title":["Biomed."],"abstract":"<jats:p>Introducci\u00f3n. La diabetes mellitus de tipo 1 se considera una de las enfermedades cr\u00f3nicas m\u00e1s frecuentes de la infancia. Es un factor de gran riesgo de desarrollar enfermedad cardiovascular temprana y afecta tambi\u00e9n la salud \u00f3sea.Objetivo. Describir las caracter\u00edsticas demogr\u00e1ficas y los par\u00e1metros bioqu\u00edmicos de una poblaci\u00f3n de ni\u00f1os con diabetes de tipo 1, supervisados en la unidad pedi\u00e1trica de diabetes de un hospital espa\u00f1ol de tercer nivel.Materiales y m\u00e9todos. En este estudio retrospectivo, se determinaron los par\u00e1metros de control metab\u00f3lico, lip\u00eddico y \u00f3seo en 124 ni\u00f1os con diabetes de tipo 1, a los que se hizo seguimiento en la Unidad Pedi\u00e1trica de Diabetes del Hospital Universitario Miguel Servet de Zaragoza, desde mayo del 2020 hasta julio del 2021.Resultados. Los ni\u00f1os con diabetes de tipo 1 presentan peor control metab\u00f3lico de la enfermedad en la pubertad, pero su control lip\u00eddico se puede considerar aceptable. Existe una correlaci\u00f3n inversa de los marcadores de formaci\u00f3n \u00f3sea con el tiempo de evoluci\u00f3n de la enfermedad, as\u00ed como con el control metab\u00f3lico.Conclusi\u00f3n. Los marcadores de formaci\u00f3n \u00f3sea se encuentran correlacionados de forma inversa con el porcentaje de hemoglobina glicosilada y con el tiempo de evoluci\u00f3n de la diabetes. En estos pacientes, el perfil lip\u00eddico y el \u00f3seo son m\u00e1s favorables cuando existe un buen control metab\u00f3lico de la enfermedad.<\/jats:p>","DOI":"10.7705\/biomedica.7132","type":"journal-article","created":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T15:40:41Z","timestamp":1722354041000},"page":"171-181","update-policy":"https:\/\/doi.org\/10.7705\/crossmark","source":"Crossref","is-referenced-by-count":1,"title":["Control gluc\u00e9mico y estudio del metabolismo lip\u00eddico y del \u00f3seo en ni\u00f1os con diabetes de tipo 1","Glycemic control and study of lipid and bone metabolism in type 1 diabetic children"],"prefix":"10.7705","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3717-8227","authenticated-orcid":false,"given":"Pilar","family":"Calmarza","sequence":"first","affiliation":[{"name":"Servicio de Bioqu\u00edmica Cl\u00ednica, Hospital Universitario Miguel Servet, Zaragoza, Espa\u00f1a; Instituto de Investigaci\u00f3n Sanitaria Arag\u00f3n (IIS Arag\u00f3n), Universidad de Zaragoza, Zaragoza, Espa\u00f1a;\u00a0Centro de Investigaci\u00f3n en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, Madrid, Espa\u00f1a"},{"name":"Servicio de Bioqu\u00edmica Cl\u00ednica, Hospital Universitario Miguel Servet, Zaragoza, Espa\u00f1a; Instituto de Investigaci\u00f3n Sanitaria Arag\u00f3n (IIS Arag\u00f3n), Universidad de Zaragoza, Zaragoza, Espa\u00f1a;\u00a0Centro de Investigaci\u00f3n en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, Madrid, Espa\u00f1a"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9610-8053","authenticated-orcid":false,"given":"Rasha Isabel","family":"P\u00e9rez-Ajami","sequence":"additional","affiliation":[{"name":"Servicio de Pediatr\u00eda, Hospital Universitario Miguel Servet, Zaragoza, Espa\u00f1a"},{"name":"Servicio de Pediatr\u00eda, Hospital Universitario Miguel Servet, Zaragoza, Espa\u00f1a"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7889-8058","authenticated-orcid":false,"given":"Carlos","family":"Prieto-L\u00f3pez","sequence":"additional","affiliation":[{"name":"Servicio de Bioqu\u00edmica Cl\u00ednica, Hospital de Alca\u00f1iz, Alca\u00f1iz, Espa\u00f1a"},{"name":"Servicio de Bioqu\u00edmica Cl\u00ednica, Hospital de Alca\u00f1iz, Alca\u00f1iz, Espa\u00f1a"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4727-7624","authenticated-orcid":false,"given":"Alba","family":"Gallego-Royo","sequence":"additional","affiliation":[{"name":"Servicio de Medicina Preventiva, Hospital Universitario Miguel Servet, Zaragoza, Espa\u00f1a"},{"name":"Servicio de Medicina Preventiva, Hospital Universitario Miguel Servet, Zaragoza, Espa\u00f1a"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1311-680X","authenticated-orcid":false,"given":"Celia","family":"Garc\u00eda-Carro","sequence":"additional","affiliation":[{"name":"Servicio de Bioqu\u00edmica Cl\u00ednica, Hospital Universitario Miguel Servet, Zaragoza, Espa\u00f1a"},{"name":"Servicio de Bioqu\u00edmica Cl\u00ednica, Hospital Universitario Miguel Servet, Zaragoza, Espa\u00f1a"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graciela Mar\u00eda","family":"Lou-Franc\u00e9s","sequence":"additional","affiliation":[{"name":"Centro de Salud de Barbastro, Barbastro, Espa\u00f1a"},{"name":"Centro de Salud de Barbastro, Barbastro, Espa\u00f1a"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4444","published-online":{"date-parts":[[2024,5,31]]},"reference":[{"key":"135733","doi-asserted-by":"crossref","unstructured":"Karvonen M, Viik-Kajander M, Moltchanova E, Libman I, LaPorte R, Tuomilehto J. Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care. 2000;23:1516-26. https:\/\/doi.org\/10.2337\/diacare.23.10.1516","DOI":"10.2337\/diacare.23.10.1516"},{"key":"135734","doi-asserted-by":"crossref","unstructured":"Mamoulakis D, Galanakis E, Bicouvarakis S, Paraskakis E, Sbyrakis S. Epidemiology of childhood type I diabetes in Crete, 1990-2001. Acta Paediatr. 2003;92:737. https:\/\/doi.org\/10.1080\/08035250310002588","DOI":"10.1111\/j.1651-2227.2003.tb00610.x"},{"key":"135735","doi-asserted-by":"crossref","unstructured":"Karvonen M, Pitk\u00e4niemi J, Tuomilehto J. The onset age of type 1 diabetes in Finnish children has become younger. The Finnish Childhood Diabetes Registry Group. Diabetes Care. 1999;22:1066. https:\/\/doi.org\/10.2337\/diacare.22.7.1066","DOI":"10.2337\/diacare.22.7.1066"},{"key":"135736","doi-asserted-by":"crossref","unstructured":"Dabelea D, Mayer-Davis EJ, Imperatore G. The value of national diabetes registries: SEARCH for Diabetes in Youth Study. Curr Diab Rep. 2010;10:362-9. https:\/\/doi.org\/10.1007\/s11892-010-0135-1","DOI":"10.1007\/s11892-010-0135-1"},{"key":"135737","doi-asserted-by":"crossref","unstructured":"Patterson C, Guariguata L, Dahlquist G, Solt\u00e9sz G, Ogle G, Silink M. Diabetes in the young - A global view and worldwide estimates of numbers of children with type 1 diabetes. Diabetes Res Clin Pract. 2014;103:161-75. http:\/\/doi.org\/10.1016\/j.diabres.2013.11.005","DOI":"10.1016\/j.diabres.2013.11.005"},{"key":"135738","doi-asserted-by":"crossref","unstructured":"Gale EA. The rise of childhood type 1 diabetes in the 20th century. Diabetes. 2002;51:3353-61 https:\/\/doi.org\/10.2337\/diabetes.51.12.3353","DOI":"10.2337\/diabetes.51.12.3353"},{"key":"135739","doi-asserted-by":"crossref","unstructured":"Kavey RE, Allada V, Daniels SR, Hayman LL, McCrindle BW, Newburger JW, et al. Cardiovascular risk reduction in high-risk pediatric patients: A scientific statement from the American Heart Association expert panel on population and prevention science; the Councils on cardiovascular disease in the young, epidemiology and prevention, nutrition, physical activity and metabolism, high blood pressure research, cardiovascular nursing, and the kidney in heart disease; and the Interdisciplinary Working Group on quality of care and outcomes research: Endorsed by the American Academy of Pediatrics. Circulation. 2006;114:2710-38. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.179568","DOI":"10.1161\/CIRCULATIONAHA.106.179568"},{"key":"135740","doi-asserted-by":"crossref","unstructured":"Vurall\u0131 D, Jalilova L, Alika\u015fifo\u011flu A, \u00d6z\u00f6n ZA, G\u00f6n\u00e7 EN, Kandemir N. Cardiovascular risk factors in adolescents with type 1 diabetes: Prevalence and gender differences. J Clin Res Pediatr Endocrinol. 2024;16:11-20. https:\/\/doi.org\/10.4274\/jcrpe.galenos.2023.2023-12-12","DOI":"10.4274\/jcrpe.galenos.2023.2023-12-12"},{"key":"135741","doi-asserted-by":"crossref","unstructured":"Siminerio LM, Albanese-O\u2019Neill A, Chiang JL, Hathaway K, Jackson CC, Weissberg-Benchell J, et al. Care of young children with diabetes in the child care setting: A position statement of the American Diabetes Association. Diabetes Care. 2014;37:2834-42. https:\/\/doi.org\/10.2337\/dc14-1676","DOI":"10.2337\/dc14-1676"},{"key":"135742","doi-asserted-by":"crossref","unstructured":"Rewers MJ, Pillay K, de Beaufort C, Craig ME, Hanas R, Acerini CL, et al. Assessment and monitoring of glycemic control in children and adolescents with diabetes. Pediatr Diabetes. 2014;15:102-14. https:\/\/doi.org\/10.1111\/pedi.12190","DOI":"10.1111\/pedi.12190"},{"key":"135743","doi-asserted-by":"crossref","unstructured":"Schwab KO, Doerfer J, Marg W, Schober E, Holl RW. DPV Science Initiative and the Competence Network Diabetes mellitus. Characterization of 33,488 children and adolescents with type 1 diabetes based on the gender-specific increase of cardiovascular risk factors. Pediatr Diabetes. 2010;11:357-63. https:\/\/doi.org\/10.1111\/j.1399-5448.2010.00665.x","DOI":"10.1111\/j.1399-5448.2010.00665.x"},{"key":"135744","doi-asserted-by":"crossref","unstructured":"Lachin JM, Bebu I, Nathan DM; DCCT\/EDIC Research Group. The beneficial effects of earlier versus later implementation of intensive therapy in type 1 diabetes. Diabetes Care. 2021;44:2225-30. https:\/\/doi.org\/10.2337\/dc21-1331","DOI":"10.2337\/dc21-1331"},{"key":"135745","doi-asserted-by":"crossref","unstructured":"Gubitosi-Klug RA; DCCT\/EDIC Research Group. The diabetes control and complications trial\/epidemiology of diabetes interventions and complications study at 30 years: Summary and future directions. Diabetes Care. 2014;37:44-9. https:\/\/doi.org\/10.2337\/dc13-2148","DOI":"10.2337\/dc13-2148"},{"key":"135746","doi-asserted-by":"crossref","unstructured":"Weber DR. Bone accrual in children and adolescents with type 1 diabetes: Current knowledge and future directions. Curr Opin Endocrinol Diabetes Obes. 2021;28:340-7. https:\/\/doi.org\/10.1097\/MED.0000000000000638","DOI":"10.1097\/MED.0000000000000638"},{"key":"135747","doi-asserted-by":"crossref","unstructured":"Dabelea D, Bell RA, D\u2019Agostino RB, Imperatore G, Johansen JM, Linder B, et al. Writing Group for the SEARCH for Diabetes in Youth Study Group. Incidence of diabetes in youth in the United States. JAMA. 2007;297:2716. https:\/\/doi.org\/10.1001\/jama.297.24.2716","DOI":"10.1001\/jama.297.24.2716"},{"key":"135748","doi-asserted-by":"crossref","unstructured":"Kordonouri O, Klingensmith G, Knip M, Holl RW, Aanstoot HJ, Menon PSN, et al. Other complications and diabetes-associated conditions in children and adolescents. Pediatr Diabetes. 2014;15:270-8. https:\/\/doi.org\/10.1111\/pedi.12183","DOI":"10.1111\/pedi.12183"},{"key":"135749","doi-asserted-by":"crossref","unstructured":"Di\u0301az-Ca\u0301rdenas C, Wonga C, Vargas-Catala\u0301n NA. Grado de control metabo\u0301lico en ni\u00f1os y adolescentes con diabetes mellitus tipo 1. Rev Chil Pediatr. 2016;87:43-7. https:\/\/doi.org\/10.1016\/j.rchipe.2015.09.002","DOI":"10.1016\/j.rchipe.2015.09.002"},{"key":"135750","doi-asserted-by":"crossref","unstructured":"Plamper M, Gohlke B, Woelfle J, Konrad K, Rohrer T, Hofer S, et al. Interaction of pubertal development and metabolic control in adolescents with type 1 diabetes mellitus. J Diabetes Res. 2017;2017:861576. https:\/\/doi.org\/10.1155\/2017\/8615769","DOI":"10.1155\/2017\/8615769"},{"key":"135751","doi-asserted-by":"crossref","unstructured":"Gerhardsson P, Schwandt A, Witsch M , Kordonouri O, Svensson J, Forsander G, et al. The SWEET Project 10-year benchmarking in 19 countries worldwide is associated with improved HbA1c and increased use of diabetes technology in youth with type 1 diabetes. Diabetes Technol Ther. 2021;23:491-9. https:\/\/doi.org\/10.1089\/dia.2020.0618","DOI":"10.1089\/dia.2020.0618"},{"key":"135752","doi-asserted-by":"crossref","unstructured":"Schwandt A, Hermann JM, Rosenbauer J, Boettcher C, Dunstheimer D, Grulich-Henn J, et al. Longitudinal trajectories of metabolic control from childhood to young adulthood in type 1 diabetes from a large German\/Austrian Registry: A Group-based modeling approach. Diabetes Care. 2017;40:309-16. https:\/\/doi.org\/10.2337\/dc16-1625","DOI":"10.2337\/dc16-1625"},{"key":"135753","doi-asserted-by":"crossref","unstructured":"Faienza MF, Ventura A, Delvecchio M, Fusillo A, Piacente L, Aceto G, et al. High sclerostin and Dickkopf-1 (DKK-1) serum levels in children and adolescents with type 1 diabetes mellitus. J Clin Endocrinol Metab. 2017;102:1174-81. https:\/\/doi.org\/10.1210\/jc.2016-2371","DOI":"10.1210\/jc.2016-2371"},{"key":"135754","doi-asserted-by":"crossref","unstructured":"Homma TK, Endo CM, Saruhashi T, Mori AP, de Noronha RM, Monte O, et al. Dyslipidemia in young patients with type 1 diabetes mellitus. Arch Endocrinol Metab. 2015;59:215-9. https:\/\/doi.org\/10.1590\/2359-3997000000040","DOI":"10.1590\/2359-3997000000040"},{"key":"135755","doi-asserted-by":"crossref","unstructured":"Selvaraj M, Prasad HK, White S, Prasanna B, Sangaralingam T. Prevalence and determinants of occurrence of dyslipidemia in subjects with type 1 diabetes mellitus. Indian J Pediatr. 2023;90:118-23. https:\/\/doi.org\/10.1007\/s12098-022-04130-2","DOI":"10.1007\/s12098-022-04130-2"},{"key":"135756","doi-asserted-by":"crossref","unstructured":"Bulut T, Demirel F, Metin A. The prevalence of dyslipidemia and associated factors in children and adolescents with type 1 diabetes. J Pediatr Endocrinol Metab. 2017;30:181-7. https:\/\/doi.org\/10.1515\/jpem-2016-0111","DOI":"10.1515\/jpem-2016-0111"},{"key":"135757","doi-asserted-by":"crossref","unstructured":"Kershnar AK, Daniels SR, Imperatore G, Palla SL, Petitti DB, Pettitt DJ, et al. Lipid abnormalities are prevalent in youth with type 1 and type 2 diabetes: The search for diabetes in youth study. J Pediatr. 2006;149:314-9. https:\/\/doi.org\/10.1016\/j.jpeds.2006.04.065","DOI":"10.1016\/j.jpeds.2006.04.065"},{"key":"135758","doi-asserted-by":"crossref","unstructured":"Macedoni M, Hovnik T, Plesnik E, Kotnik P, Bratina N, Battelino T, et al. Metabolic control, ApoE genotypes, and dyslipidemia in children, adolescents and young adults with type 1 diabetes. Atherosclerosis. 2018;273:53-8. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.04.013","DOI":"10.1016\/j.atherosclerosis.2018.04.013"},{"key":"135759","doi-asserted-by":"crossref","unstructured":"Petitti DB, Imperatore G, Palla SL, Daniels SR, Dolan LM, Kershnar AK, et al. Serum lipids and glucose control: The SEARCH for Diabetes in Youth study. Arch Pediatr Adolesc Med. 2007;161:159-65. https:\/\/doi.org\/10.1001\/archpedi.161.2.159","DOI":"10.1001\/archpedi.161.2.159"},{"key":"135760","doi-asserted-by":"crossref","unstructured":"Frontini MG, Srinivasan SR, Xu J, Tang R, Bond MG, Berenson GS. Usefulness of childhood non-high density lipoprotein cholesterol levels versus other lipoprotein measures in predicting adult subclinical atherosclerosis: The Bogalusa Heart Study. Pediatr. 2008;121:924-9. https:\/\/doi.org\/10.1542\/peds.2007-1472","DOI":"10.1542\/peds.2007-1472"},{"key":"135761","unstructured":"Dorchy H. Screening for subclinical complications in children and adolescents with type 1 diabetes: Experience acquired in Brussels. Rev Med Brux. 2010;31:S87-108."},{"key":"135762","doi-asserted-by":"crossref","unstructured":"Abd-El Dayem SM, El-Shehaby AM, Abd-El Gafar A, Fawzy A, Salama H. Bone density, body composition, and markers of bone remodeling in type 1 diabetic patients. Scand J Clin Lab Invest. 2011;71:387-93. https:\/\/doi.org\/10.3109\/00365513.2011.573574","DOI":"10.3109\/00365513.2011.573574"},{"key":"135763","doi-asserted-by":"crossref","unstructured":"Maggio AB, Ferrari S, Kraenzlin M, Marchand LM, Schwitzgebel V, Beghetti M, et al. Decreased bone turnover in children and adolescents with well controlled type 1 diabetes. J Pediatr Endocrinol Metab. 2010;23:697-707. https:\/\/doi.org\/10.1515\/jpem.2010.23.7.697","DOI":"10.1515\/JPEM.2010.23.7.697"},{"key":"135764","doi-asserted-by":"crossref","unstructured":"Pater A, Sypniewska G, Pilecki O. Biochemical markers of bone cell activity in children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2010;23:81-6. https:\/\/doi.org\/10.1515\/jpem.2010.23.1-2.81","DOI":"10.1515\/JPEM.2010.23.1-2.81"},{"key":"135765","doi-asserted-by":"crossref","unstructured":"Madsen JOB, J\u00f8rgensen NR, Pociot F, Johannesen J. Bone turnover markers in children and adolescents with type 1 diabetes - A systematic review. Pediatr Diabetes. 2019;20:510-22. https:\/\/doi.org\/10.1111\/pedi.12853","DOI":"10.1111\/pedi.12853"},{"key":"135766","doi-asserted-by":"crossref","unstructured":"Tsenditis C, Gourgiotis D, Kossiva L, Doulgeraki A, Marmarinos A, Galli-Tsinopoulou A, et al. Higher levels of s-RANKL and osteoprotegerin in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast signaling and predisposition to lower bone mass: A multivariate cross-sectional analysis. Osteoporos Int. 2016;27:1631-43. https:\/\/doi.org\/10.1007\/s00198-015-3422-5","DOI":"10.1007\/s00198-015-3422-5"},{"key":"135767","doi-asserted-by":"crossref","unstructured":"Onder A, Cetinkaya S, Tunc O, Aycan Z. Evaluation of bone mineral density in children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2013;26:1077-81. https:\/\/doi.org\/10.1515\/jpem-2012-0369","DOI":"10.1515\/jpem-2012-0369"},{"key":"135768","doi-asserted-by":"crossref","unstructured":"Brandao FR, Vicente EJ, Daltro CH, Sacramento M, Moreira A, Adan L. Bone metabolism is linked to disease duration and metabolic control in type 1 diabetes mellitus. Diabetes Res Clin Pract. 2007;78:334-9. https:\/\/doi.org\/10.1016\/j.diabres.2007.04.009","DOI":"10.1016\/j.diabres.2007.04.009"},{"key":"135769","doi-asserted-by":"crossref","unstructured":"Madsen JOB, Herskin CW, Zerahn B, J\u00f8rgensen NR, Olsen BS, Pociot F, et al. Decreased markers of bone turnover in children and adolescents with type 1 diabetes. J Bone Miner Metab. 2020;38:328-37. https:\/\/doi.org\/10.1007\/s00774-019-01058-0","DOI":"10.1007\/s00774-019-01058-0"},{"key":"135770","doi-asserted-by":"crossref","unstructured":"V\u00e1zquez-G\u00e1mez MA, Bocio-N\u00fa\u00f1ez J, Berm\u00fadez-de la Vega JA, Bernal-Cerrato S, Giner-Garc\u00eda M, Miranda-Garc\u00eda MJ, et al. Cambios en la masa \u00f3sea en una poblaci\u00f3n infantil con diabetes mellitus tipo 1. Estudio longitudinal. Rev Osteoporos Metab Miner. 2022;14:82-7.","DOI":"10.4321\/S1889-836X2022000200004"},{"key":"135771","doi-asserted-by":"crossref","unstructured":"Liu EY, Wactawski-Wende J, Donahue RP, Dmochowski J, Hovey KM, Quattrin T. Does low bone mineral density start in post-teenage years in women with type 1 diabetes? Diabetes Care. 2003;26:2365-9. https:\/\/doi.org\/10.2337\/diacare.26.8.2365","DOI":"10.2337\/diacare.26.8.2365"}],"container-title":["Biom\u00e9dica"],"original-title":[],"link":[{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/7132\/5545","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/7132\/5627","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/7132\/5545","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T14:11:02Z","timestamp":1773324662000},"score":1,"resource":{"primary":{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/view\/7132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,31]]},"references-count":39,"journal-issue":{"issue":"Sp. 1","published-online":{"date-parts":[[2024,5,31]]}},"URL":"https:\/\/doi.org\/10.7705\/biomedica.7132","relation":{},"ISSN":["2590-7379","0120-4157"],"issn-type":[{"value":"2590-7379","type":"electronic"},{"value":"0120-4157","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,31]]},"assertion":[{"value":"2024-05-31","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}},{"value":"Yes","order":0,"name":"peer_reviewed","label":"Peer Reviewed","group":{"name":"peer_review","label":"Peer Review"}},{"value":"Instituto Nacional de Salud","name":"publisher","label":"This article is maintained by"},{"value":"Biomedica","name":"journaltitle","label":"Journal Title"},{"value":"Art\u00edculos originales","name":"content_type","label":"Content Type"}]}}